Clinical trial: Preliminary efficacy and safety study of a new Budesonide-MMX® 9 mg extended-release tablets in patients with active left-sided ulcerative colitis. [electronic resource]
Producer: 20110509Description: 153-60 p. digitalISSN:- 1876-4479
- Administration, Oral
- Adult
- Anti-Inflammatory Agents -- administration & dosage
- Biomarkers -- metabolism
- Biopsy
- Budesonide -- administration & dosage
- C-Reactive Protein -- metabolism
- Colitis, Ulcerative -- drug therapy
- Colonoscopy
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Intestinal Mucosa -- pathology
- Male
- Middle Aged
- Pilot Projects
- Remission Induction
- Severity of Illness Index
- Tablets, Enteric-Coated
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.